Your browser doesn't support javascript.
loading
Post-mortem investigation of deaths due to pneumonia in children aged 1-59 months in sub-Saharan Africa and South Asia from 2016 to 2022: an observational study.
Mahtab, Sana; Blau, Dianna M; Madewell, Zachary J; Ogbuanu, Ikechukwu; Ojulong, Julius; Lako, Sandra; Legesse, Hailemariam; Bangura, Joseph S; Bassat, Quique; Mandomando, Inacio; Xerinda, Elisio; Fernandes, Fabiola; Varo, Rosauro; Sow, Samba O; Kotloff, Karen L; Tapia, Milagritos D; Keita, Adama Mamby; Sidibe, Diakaridia; Onyango, Dickens; Akelo, Victor; Gethi, Dickson; Verani, Jennifer R; Revathi, Gunturu; Scott, J Anthony G; Assefa, Nega; Madrid, Lola; Bizuayehu, Hiwot; Tirfe, Tseyon Tesfaye; El Arifeen, Shams; Gurley, Emily S; Islam, Kazi Munisul; Alam, Muntasir; Zahid Hossain, Mohammad; Dangor, Ziyaad; Baillie, Vicky L; Hale, Martin; Mutevedzi, Portia; Breiman, Robert F; Whitney, Cynthia G; Madhi, Shabir A.
Afiliación
  • Mahtab S; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Blau DM; Global Health Center, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Madewell ZJ; Global Health Center, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Ogbuanu I; Crown Agents, Freetown, Sierra Leone.
  • Ojulong J; ICAP - Columbia University, Makeni, Sierra Leone.
  • Lako S; Aberdeen Women's Centre, Freetown, Sierra Leone.
  • Legesse H; UNICEF Sierra Leone, Freetown, Sierra Leone.
  • Bangura JS; Caritas International-Sierra Leone, Freetown, Sierra Leone.
  • Bassat Q; Centro de Investigação em Saúde de Manhiça, Maputo, Mozambique; ISGlobal - Hospital Clínic, Unversitat de Barcelona, Barcelona, Spain; Institutó Catalana de Recerca I Estudis Avançats, Barcelona, Spain; Pediatrics Department, Hospital Sant Joan de Déu, Universitat de Barcelona, Esplugues, Barcelona,
  • Mandomando I; Centro de Investigação em Saúde de Manhiça, Maputo, Mozambique; Instituto Nacional de Saúde, Maputo, Mozambique.
  • Xerinda E; Centro de Investigação em Saúde de Manhiça, Maputo, Mozambique.
  • Fernandes F; Department of Pathology, Maputo Central Hospital, Maputo, Mozambique.
  • Varo R; Centro de Investigação em Saúde de Manhiça, Maputo, Mozambique; ISGlobal - Hospital Clínic, Unversitat de Barcelona, Barcelona, Spain.
  • Sow SO; Centre pour le Développement des Vaccins, Ministère de la Santé, Bamako, Mali.
  • Kotloff KL; Department of Pediatrics and Department of Medicine, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Tapia MD; Department of Pediatrics and Department of Medicine, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Keita AM; Centre pour le Développement des Vaccins, Ministère de la Santé, Bamako, Mali.
  • Sidibe D; Centre pour le Développement des Vaccins, Ministère de la Santé, Bamako, Mali.
  • Onyango D; Kisumu County Department of Health, Kisumu, Kenya.
  • Akelo V; Centers for Disease Control and Prevention-Kenya, Kisumu, Kenya.
  • Gethi D; Kenya Medical Research Institute-Center for Global Health Research (KEMRI-CGHR), Kisumu, Kenya.
  • Verani JR; National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Revathi G; Department of Pathology, Aga Khan University, Nairobi, Kenya.
  • Scott JAG; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.
  • Assefa N; College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.
  • Madrid L; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK; College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.
  • Bizuayehu H; Department of Microbiology, Addis Ababa Burn, Emergency and Trauma Hospital, Addis Ababa, Ethiopia.
  • Tirfe TT; College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.
  • El Arifeen S; International Center for Diarrhoeal Diseases Research, Dhaka, Bangladesh.
  • Gurley ES; International Center for Diarrhoeal Diseases Research, Dhaka, Bangladesh; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • Islam KM; International Center for Diarrhoeal Diseases Research, Dhaka, Bangladesh.
  • Alam M; International Center for Diarrhoeal Diseases Research, Dhaka, Bangladesh.
  • Zahid Hossain M; International Center for Diarrhoeal Diseases Research, Dhaka, Bangladesh.
  • Dangor Z; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Baillie VL; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Hale M; National Health Laboratory Service, Department of Anatomical Pathology, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Mutevedzi P; Emory Global Health Institute, Emory University, Atlanta, Georgia, USA.
  • Breiman RF; Wits Infectious Diseases and Oncology Research Institute, University of the Witwatersrand, Faculty of Health Sciences, Johannesburg, South Africa.
  • Whitney CG; Emory Global Health Institute, Emory University, Atlanta, Georgia, USA.
  • Madhi SA; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Wits Infectious Diseases and Oncology Research Institute, University of the Witwatersrand, Faculty of Health Scien
Lancet Child Adolesc Health ; 8(3): 201-213, 2024 Mar.
Article en En | MEDLINE | ID: mdl-38281495
ABSTRACT

BACKGROUND:

The Child Health and Mortality Prevention Surveillance (CHAMPS) Network programme undertakes post-mortem minimally invasive tissue sampling (MITS), together with collection of ante-mortem clinical information, to investigate causes of childhood deaths across multiple countries. We aimed to evaluate the overall contribution of pneumonia in the causal pathway to death and the causative pathogens of fatal pneumonia in children aged 1-59 months enrolled in the CHAMPS Network.

METHODS:

In this observational study we analysed deaths occurring between Dec 16, 2016, and Dec 31, 2022, in the CHAMPS Network across six countries in sub-Saharan Africa (Ethiopia, Kenya, Mali, Mozambique, Sierra Leone, and South Africa) and one in South Asia (Bangladesh). A standardised approach of MITS was undertaken on decedents within 24-72 h of death. Diagnostic tests included blood culture, multi-organism targeted nucleic acid amplifications tests (NAATs) of blood and lung tissue, and histopathology examination of various organ tissue samples. An interdisciplinary expert panel at each site reviewed case data to attribute the cause of death and pathogenesis thereof on the basis of WHO-recommended reporting standards.

FINDINGS:

Pneumonia was attributed in the causal pathway of death in 455 (40·6%) of 1120 decedents, with a median age at death of 9 (IQR 4-19) months. Causative pathogens were identified in 377 (82·9%) of 455 pneumonia deaths, and multiple pathogens were implicated in 218 (57·8%) of 377 deaths. 306 (67·3%) of 455 deaths occurred in the community or within 72 h of hospital admission (presumed to be community-acquired pneumonia), with the leading bacterial pathogens being Streptococcus pneumoniae (108 [35·3%]), Klebsiella pneumoniae (78 [25·5%]), and non-typeable Haemophilus influenzae (37 [12·1%]). 149 (32·7%) deaths occurred 72 h or more after hospital admission (presumed to be hospital-acquired pneumonia), with the most common pathogens being K pneumoniae (64 [43·0%]), Acinetobacter baumannii (19 [12·8%]), S pneumoniae (15 [10·1%]), and Pseudomonas aeruginosa (15 [10·1%]). Overall, viruses were implicated in 145 (31·9%) of 455 pneumonia-related deaths, including 54 (11·9%) of 455 attributed to cytomegalovirus and 29 (6·4%) of 455 attributed to respiratory syncytial virus.

INTERPRETATION:

Pneumonia contributed to 40·6% of all childhood deaths in this analysis. The use of post-mortem MITS enabled biological ascertainment of the cause of death in the majority (82·9%) of childhood deaths attributed to pneumonia, with more than one pathogen being commonly implicated in the same case. The prominent role of K pneumoniae, non-typable H influenzae, and S pneumoniae highlight the need to review empirical management guidelines for management of very severe pneumonia in low-income and middle-income settings, and the need for research into new or improved vaccines against these pathogens.

FUNDING:

Bill & Melinda Gates Foundation.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neumonía Tipo de estudio: Guideline / Observational_studies / Prognostic_studies Límite: Child / Humans / Infant País/Región como asunto: Africa / Asia Idioma: En Revista: Lancet Child Adolesc Health Año: 2024 Tipo del documento: Article País de afiliación: Sudáfrica

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neumonía Tipo de estudio: Guideline / Observational_studies / Prognostic_studies Límite: Child / Humans / Infant País/Región como asunto: Africa / Asia Idioma: En Revista: Lancet Child Adolesc Health Año: 2024 Tipo del documento: Article País de afiliación: Sudáfrica